Skip to content

TETRAPHASE PHARMACEUTICALS INC

CIK 0001373707

← back to feed
Revenue (TTM)
$7.44M
−49.4% YoY Q1 May 2020
Net Income (TTM)
−$70.84M
+30.3% YoY Q1 May 2020
EPS Diluted (TTM)
—
Q1 May 2020
Gross Margin
—
Q1 May 2020
Operating Margin
-917.3%
Q1 May 2020
Net Margin
-952.0%
Q1 May 2020
Free Cash Flow (TTM)
−$53.48M
Q1 May 2020
Cash
$26.15M
Q1 May 2020
Total Debt
$28.75M
Q1 May 2020
Shares Outstanding
7.26M sh
Q1 May 2020

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings